Treatment by CRISPR-Cas9 Gene Editing - A Proof of Principle
N Engl J Med
.
2021 Jan 21;384(3):286-287.
doi: 10.1056/NEJMe2034624.
Author
Harry L Malech
1
Affiliation
1
From the Genetic Immunotherapy Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.
PMID:
33471982
DOI:
10.1056/NEJMe2034624
No abstract available
Publication types
Editorial
Comment
MeSH terms
Anemia, Sickle Cell*
CRISPR-Cas Systems
Clustered Regularly Interspaced Short Palindromic Repeats
Gene Editing
Humans
beta-Thalassemia*